TCL Archive Centers Of Excellence In Interventions Aimed at molecular Targets; Approved On 19-6 Vote July 2, 1999
TCL Archive In Brief: Oldham To Head Biological Response Modifiers Program; Walter, Namovicz Named Acting Heads August 8, 1980
TCL Archive Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival April 27, 2012